论文部分内容阅读
目的探讨静脉丙种球蛋白(IVIG)在治疗婴幼儿重症肺炎时的疗效。方法将住院76例重症肺炎婴幼儿随机分为治疗组(38例)和对照组(38例),对照组给予抗感染、氧疗、强心、镇静等常规治疗,治疗组在常规治疗基础上应用静脉注射丙种球蛋白治疗,对两组患儿疗效进行对照分析。结果治疗组疗效明显优于对照组,起效快,两者比较,差异有统计学意义(P<0.01)。结论丙种球蛋白治疗婴幼儿重症肺炎疗效显著,值得临床应用。
Objective To investigate the efficacy of intravenous gamma globulin (IVIG) in the treatment of infantile severe pneumonia. Methods 76 cases of severe pneumonia infants were randomly divided into treatment group (38 cases) and control group (38 cases). The control group was given anti-infection, oxygen therapy, cardioplegia, sedation and other conventional treatment. The treatment group was treated on the basis of routine treatment The application of intravenous gamma globulin treatment, the efficacy of two groups of children were analyzed. Results The treatment group was significantly better than the control group, rapid onset, the two, the difference was statistically significant (P <0.01). Conclusion Gamma globulin is effective in treating severe pneumonia in infants and young children. It is worthy of clinical application.